M.Sc., University College London
Ph.D., Nanyang Technological University – A*STAR joint program
Postdoc Fellow, Singapore Immunology Network, A*STAR
Senior Research Scientist, Massachusetts General Hospital, Harvard Medical School
Hepatocellular carcinoma (HCC) often develops following chronic hepatitis B virus (HBV) infection and responds poorly to immune checkpoint blockade. Here, we examined the antigen specificities of HCC-infiltrating T cells and their relevance to tumor control.